New research reveals that people who come off blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle programs.
Findings released in a major medical journal shows that while obese people can lose about a fifth of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using such medications need to be aware of the potential of fast rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.
This pace of recovery suggests a reversion to starting mass within about 18 months.
Analyzing Approaches
The research, which examined dozens of trials involving over 9,000 of participants, contrasted the results of GLP-1 agonists with conventional dieting.
The team emphasize that individuals who lose weight through dieting usually have a more gradual creep back—perhaps 100 grams monthly—once they finish.
The Reason for the Quick Rebound
Nutrition scientists propose the mechanism of the jabs accounts for the amplified weight return.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which controls hunger.
"Sustained high doses of GLP-1 concentrations several times higher than normal might result in the system to produce less of its own natural hormone, and could reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Stopping of this hormone supplement results in appetite is unsuppressed, making overeating far more likely."
A Lifelong Condition?
Health authorities recommend the injections for people with obesity-related health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, due to the likelihood of weight regain, the treatment might need to be life-long.
This opinion is echoed by pharmaceutical companies, who note that the results "underscore the persistent character of excess weight," similar to managing diseases like hypertension.
Patient Testimonies
Users who have come off the medication describe a intense resurgence of appetite.
"I experienced a trigger that goes on and you become starving," recalled a patient.
This challenge is exacerbated if patients have not adopted permanent lifestyle or habit modifications during treatment.
Growing Adoption
Recent estimates suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Use is higher among women compared to males.
- The middle-aged demographic shows the greatest usage rates.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, researchers emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a standalone solution and lasting health benefits hinges on combined lifestyle management.
